Naya Biosciences, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Armistice Capital, LLC and Steven Boyd have filed a Schedule 13G, reporting beneficial ownership of 120,537 shares of INVO FERTILITY, INC. common stock, representing 4.99% of the class.
Alumni Capital LP, along with its general partner and controlling person, has reported beneficial ownership of 9.99% of INVO Fertility, Inc. common stock, primarily through an Any Market Purchase Agreement.
Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 9.99% of INVO Fertility, Inc. common stock as of March 31, 2026.
Glenbrook Capital Management has reported a beneficial ownership of 8.33% of INVO Fertility, Inc.'s common stock, totaling 134,515 shares.
Five Narrow Lane LP filed an amended Schedule 13G, reporting beneficial ownership of 0.29% of INVO Fertility, Inc.'s common stock.
Greenblock Capital, LLC and its manager Christopher Spencer have disclosed a 9.99% beneficial ownership stake in INVO Fertility, Inc., totaling 617,954 common shares.
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has filed an amended Schedule 13G disclosing a beneficial ownership of 4.99% in INVO Fertility, Inc.'s common stock.
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a beneficial ownership of 6.9% in NAYA Biosciences Inc. common stock, totaling 504,478 shares.
Five Narrow Lane LP has disclosed a 9.99% beneficial ownership stake in NAYA BIOSCIENCE INC., holding 708,074 shares of common stock as of January 14, 2025.